Biofilm of Candida albicans: formation, regulation and resistance

R Pereira, RO Dos Santos Fontenelle… - Journal of Applied …, 2021 - academic.oup.com
Candida albicans is the most common human fungal pathogen, causing infections that
range from mucous membranes to systemic infections. The present article provides an …

[HTML][HTML] Invasive candidiasis

PG Pappas, MS Lionakis, MC Arendrup… - Nature Reviews …, 2018 - nature.com
Invasive candidiasis is an important health-care-associated fungal infection that can be
caused by several Candida spp.; the most common species is Candida albicans, but the …

Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016

MA Pfaller, DJ Diekema, JD Turnidge… - Open forum …, 2019 - academic.oup.com
Background The emergence of antifungal resistance threatens effective treatment of
invasive fungal infection (IFI). Invasive candidiasis is the most common health care …

Global and multi-national prevalence of fungal diseases—estimate precision

F Bongomin, S Gago, RO Oladele, DW Denning - Journal of fungi, 2017 - mdpi.com
Fungal diseases kill more than 1.5 million and affect over a billion people. However, they are
still a neglected topic by public health authorities even though most deaths from fungal …

Drug-resistant fungi: an emerging challenge threatening our limited antifungal armamentarium

A Arastehfar, T Gabaldón, R Garcia-Rubio, JD Jenks… - Antibiotics, 2020 - mdpi.com
The high clinical mortality and economic burden posed by invasive fungal infections (IFIs),
along with significant agricultural crop loss caused by various fungal species, has resulted in …

Changes in the epidemiological landscape of invasive candidiasis

F Lamoth, SR Lockhart, EL Berkow… - Journal of …, 2018 - academic.oup.com
The epidemiology of invasive candidiasis has evolved in recent years, warranting a review
of the changes and the implications for current and future diagnosis and treatment. The …

Epidemiology and risk factors for invasive candidiasis

N Yapar - Therapeutics and clinical risk management, 2014 - Taylor & Francis
The number of immunosuppressive patients has increased significantly in recent years.
These patients are at risk for opportunistic infections, especially fungal infections …

[HTML][HTML] Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis

P Koehler, M Stecher, OA Cornely, D Koehler… - Clinical microbiology …, 2019 - Elsevier
Objectives Candidaemia is a serious hazard to hospitalized patients, but European
epidemiological data are restricted to national studies focusing on Northern Europe …

[HTML][HTML] European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: Results from the ECMM Candida III study

MC Arendrup, S Arikan-Akdagli, KM Jørgensen… - Journal of Infection, 2023 - Elsevier
The objectives of this study were to assess Candida spp. distribution and antifungal
resistance of candidaemia across Europe. Isolates were collected as part of the third ECMM …

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections

MC Arendrup, T Boekhout, M Akova… - Clinical Microbiology …, 2014 - Wiley Online Library
The mortality associated with invasive fungal infections remains high with that involving rare
yeast pathogens other than C andida being no exception. This is in part due to the severe …